Systematic mining of the human microbiome identifies antimicrobial peptides with diverse activity spectra

Nat Microbiol. 2023 Dec;8(12):2420-2434. doi: 10.1038/s41564-023-01524-6. Epub 2023 Nov 16.

Abstract

Human-associated bacteria secrete modified peptides to control host physiology and remodel the microbiota species composition. Here we scanned 2,229 Human Microbiome Project genomes of species colonizing skin, gastrointestinal tract, urogenital tract, mouth and trachea for gene clusters encoding RiPPs (ribosomally synthesized and post-translationally modified peptides). We found 218 lanthipeptides and 25 lasso peptides, 70 of which were synthesized and expressed in E. coli and 23 could be purified and functionally characterized. They were tested for activity against bacteria associated with healthy human flora and pathogens. New antibiotics were identified against strains implicated in skin, nasal and vaginal dysbiosis as well as from oral strains selectively targeting those in the gut. Extended- and narrow-spectrum antibiotics were found against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococci. Mining natural products produced by human-associated microbes will enable the elucidation of ecological relationships and may be a rich resource for antimicrobial discovery.

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Antimicrobial Peptides
  • Bacteria / genetics
  • Escherichia coli
  • Humans
  • Methicillin-Resistant Staphylococcus aureus*
  • Microbiota* / genetics
  • Peptides / chemistry
  • Peptides / genetics
  • Peptides / pharmacology

Substances

  • Antimicrobial Peptides
  • Peptides
  • Anti-Bacterial Agents